3/24/2026LG Chem's Tigulixostat Advances to Phase 3 in China Through Innovent P...

3/24/2026Sanofi Opens Chengdu Innovation Hub to Strengthen China Operations

3/24/2026Chinese Commerce Minister Meets PhRMA, MNC Executives to Discuss Indus...

3/24/2026RemeGen's Disitamab Vedotin Approved in China for HER2-Low Breast Canc...

3/24/2026Kali Therapeutics Licenses Tri-Specific TCE KT501 to Sanofi in Global ...

3/24/2026WuXi AppTec Leans Further on US Market as Other Revenues Weaken

3/24/2026Novartis Commits $480M to Expand China Footprint

3/23/2026Mabgalaxy Raises Near CNY 100M Angel Round to Advance AI-Driven Antibo...

3/23/2026Everest Medicines Acquires Greater China Rights to Etripamil Nasal Spr...

3/23/2026Sun-Novo Licenses STC007 to Salubris Pharma in Greater China Deal Wort...

3/23/2026Dizal Reports Positive Phase III WU-KONG28 Results for Sunvozertinib i...

3/23/2026CTTQ Reports Updated Phase I Data for EGFR/c-MET Bispecific TQB2922 in...

3/23/2026Earendil Labs Raises $787M to Scale AI-Driven Biologics Platform

3/23/2026Rigerna Therapeutics Raises CNY 200M+ Pre-A to Advance Kidney-Targeted...

3/23/2026Leaderna Thera Raises RMB150M Series A to Advance Oligonucleotide Pipe...

3/23/2026Hengrui Expands HER3 ADC SHR-A2009 Data Across Mono and Combination Se...

3/23/2026MediLink Thera Reports Phase II Activity for YL202/BNT326 in NSCLC

3/23/2026SkyeMedicine Raises ¥100M+ Seed to Advance Multi-Target CAR-T Pipelin...

3/23/2026HUTCHMED Advances HMPL-760 Into Phase III Trial for DLBCL in China

3/23/2026Zuellig Pharma Acquires Expanded Asia Rights to Cialis from Eli Lilly

3/20/2026Recent Executive Moves

3/20/2026Cloudbreak Pharma Withdraws China IND for CBT-009, Refocuses Ophthalmo...

3/20/2026Kintor Reports Positive Phase III Results for First-in-Class Hair Loss...

3/20/2026Excalipoint Launches With $68.7M Seed to Advance Next-Generation TCE P...

3/20/2026NovaBridge Secures FDA Alignment on Accelerated Pathway for Givastomig...

3/20/2026ELCC 2026: BioKin–Henlius Combo Shows First-Line Promise in ES-SCLC

3/20/2026Alebund Licenses First-in-Class Kidney Drug AP306 to R1 Therapeutics i...

3/20/2026AstraZeneca Expands UK–China Strategy With Cell Therapy R&D Hub and M...

3/17/2026NHSA: China Medical Insurance Revenue Growth Outpaces Spending in 2025

3/17/2026Innorna Wins FDA Clearance to Test mRNA Therapy for Refractory Gout in...

Page:1/61 Total number of articles:1813: [First][<<] [1] [2] [3] [4] [5] [>>] [End]